Pharmacogenomics of statin therapy: any new insights in efficacy or safety?
PURPOSE OF REVIEW: To examine the current evidence concerning the effects of genetic variation on statin-related low-density lipoprotein cholesterol reductions, clinical efficacy, and adverse events and the relevance for patient care. RECENT FINDINGS: Recent years have seen the emergence of large-sc...
Hoofdauteurs: | Hopewell, J, Reith, C, Armitage, J |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Lippincott Williams and Wilkins
2014
|
Gelijkaardige items
-
Interpretation of the evidence for the efficacy and safety of statin therapy
door: Collins, R, et al.
Gepubliceerd in: (2016) -
Safety and efficacy of statins - Authors' reply
door: Collins, R, et al.
Gepubliceerd in: (2017) -
Efficacy and safety of statin therapy in older people: meta-analysis of individual participant data from 28 randomised controlled trials
door: Cholesterol Treatment Trialists' Collaboration, et al.
Gepubliceerd in: (2019) -
Pharmacogenomics Statins: Biomarkers for Clinical Prediction
door: Herni Suprapti
Gepubliceerd in: (2018-09-01) -
The safety of statins in clinical practice.
door: Armitage, J
Gepubliceerd in: (2007)